1V136,
9-benzyl-8-hydroxy-2-(2-methoxyethoxy)adenine,
SM360320,
226907-52-4,
6-Amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol,
TLR7 Ligand II,
Toll-Like Receptor 7 Ligand II,
SM-360320,
CHEMBL210884,
9-Benzyl-8-hydroxy-2-(2-methoxyethoxy)adenine,
SCHEMBL43700,
CTK4E9949,
CTK8G3503,
DTXSID60434307,
YYCDGEZXHXHLGW-UHFFFAOYSA-N,
BCP26295,
ZINC3938690,
7741AD,
ABP000809,
ANW-57452,
BDBM50189516,
IN1442,
9-benzyl-2-methoxyethoxy-8-oxoadenine,
AKOS015995219,
API0014408,
BCP9000189,
LS40146,
CL087; SM360320,
SM360320,
TC-146197,
9-benzyl-2-(2-methoxyethoxy)-8-oxoadenine,
J3.545.758E,
9-benzyl-8-hydroxy-2-(2-methoxyethoxy) adenine,
J-014813,
6-Amino-9-benzyl-2-(2-methoxy-ethoxy)-9H-purin-8-ol,
6-amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol /,
6-Amino-9-benzyl-8-hydroxy-2-(2-methoxyethoxy)purine,
6-amino-9-benzyl-2-(2-methoxyethoxy)-7H-purin-8(9H)-one,
6-amino-9-benzyl-2-(2-methoxyethoxy)-7,9-dihydro-8H-purin-8-one,
6-Amino-7,9-dihydro-2-(2-methoxyethoxy)-9-(phenylmethyl)-8H-purin-8-one,
C15H17N5O3,
CID10018576,
CL087(SM360320),
A12683,